Serum adipocytokines and adiposity as predictive indices of preeclampsia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemical markers and preeclampsia (PE). Available evidence point to changes in the levels of these adipokines in PE hence this study examined the potential of using these biomarkers in the prediction of the disease. Methods: This was a case-control study which compared first trimester serum biochemical and anthropometric parameters in pregnant women who subsequently developed PE and those who did not. Blood pressure and urine protein were determined after 20 weeks of gestation and diagnosis of PE performed according to the guidelines of the American Heart Association. Results: There was no significant difference (p > 0.05) in the lipid profile with the exception of HDL cholesterol which was significantly lower (p = 0.043) in the PE group compared to the normotensive group. There were, however, significant differences (p < 0.05) in the adipokines between the PE group and those without PE. Analyses of area under the receiver operating characteristic curves (AUCs) for the adipokines, showed their ability to correctly predict PE even after controlling for body mass index (BMI) and family history of hypertension. Conclusion: Adiponectin, leptin, resistin and visfatin were found to be significant predictors of PE, with resistin being the best predictor after controlling for BMI. However, adiponectin was the best predictor after controlling for BMI, age, parity and family history of diabetes and preeclmapsia.
Abstract
Background: This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemical markers and preeclampsia (PE). Available evidence point to changes in the levels of these adipokines in PE hence this study examined the potential of using these biomarkers in the prediction of the disease. Methods: This was a case-control study which compared first trimester serum biochemical and anthropometric parameters in pregnant women who subsequently developed PE and those who did not. Blood pressure and urine protein were determined after 20 weeks of gestation and diagnosis of PE performed according to the guidelines of the American Heart Association. Results: There was no significant difference (p > 0.05) in the lipid profile with the exception of HDL cholesterol which was significantly lower (p = 0.043) in the PE group compared to the normotensive group. There were, however, significant differences (p < 0.05) in the adipokines between the PE group and those without PE. Analyses of area under the receiver operating characteristic curves (AUCs) for the adipokines, showed their ability to correctly predict PE even after controlling for body mass index (BMI) and family history of hypertension. Conclusion: Adiponectin, leptin, resistin and visfatin were found to be significant predictors of PE, with resistin being the best predictor after controlling for BMI. However, adiponectin was the best predictor after controlling for BMI, age, parity and family history of diabetes and preeclmapsia.
참고문헌 (53)
- Kirkendall WM, "Recommendations for human blood pressure determination by sphygmomanometers", Circulation, 36(6), pp.980~988 (1967)
- Backes CH, "Maternal preeclampsia and neonatal outcomes", J Preg, 4(1), pp.2011~2021 (2011)
- Wagner LK, "Diagnosis and management of preeclampsia", Am Fam Physician, 70(12), pp.2317~2324 (2004)
- Obed S, "Pregnancy following eclampsia : a longitudinal study at Korle-BU teaching hospital", Ghana Med J, 41(3), pp.1~4 (2007)
- Owiredu W, "The prevalence of the metabolic syndrome among Ghanaian pregnancy-induced hypertensive patients using the World Health Organisation and the National Cholesterol Education program III criteria", J Med Sci, 8(5), pp.443~451 (2008)
- Yeboah FA, "Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsia", Int J Women's Health, 9, pp.449~ (2017)
- Miehle K, "Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia", Clin Endocrinol, 76(1), pp.2~11 (2012)
- Hendler I, "The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia", Am J Obstet Gynecol, 193(3), pp.979~983 (2005)
- Kajantie E, "Adiponectin concentrations in maternal serum : elevated in preeclampsis but unrelated to insulin sensitivity", J Soc Gynecol Investig, 12(6), pp.433~439 (2005)
- Haugen F, "Increased plasma levels of adipokines in preeclampsia : relationship to placenta and adipose tissue gene expression", Am J Physiol Endocrinol Metab, 290(2), pp.E326~E333 (2006)
- Anim-Nyame N, "Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and preeclampsia", Hum Reprod, 15(9), pp.2033~2036 (2000)
- Chappell LC, "A longitudinal study of biochemical variables in women at risk of preeclampsia", Am J Obstet Gynecol, 187(1), pp.127~136 (2002)
- Schubring C, "Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth : relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels", Horm Res Paediatrics, 50(5), pp.276~283 (1998)
- Martinez-Abundis E, "Serum leptin levels and the severity of preeclampsia", Arch Gynecol Obstet, 264(2), pp.71~73 (2000)
- Cortelazzi D, "Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies", Clin Endocrinol, 66(3), pp.447~453 (2007)
- Kielstein JT, "Increased resistin blood levels are not associated with insulin resistance in patients with renal disease", Am J Kidney Dis, 42(1), pp.62~66 (2003)
- Fasshauer M, "Serum levels of the adipokine visfatin are increased in pre-eclampsia", Clin Endocrinol, 69(1), pp.69~73 (2008)
- Hu W, "Serum visfatin levels in late pregnancy and pre-eclampsia", Acta Obstet Gynecol Scand, 87(4), pp.413~418 (2008)
- Mazaki-Tovi S, "Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate", J Matern Fetal Neonatal Med, 23(10), pp.1119~1128 (2010)
- Salameh WA, "Maternal hyperlipidemia in pregnancy", Clin Obstet Gynecol, 37(1), pp.66~77 (1994)
- Gürsoy A, "Severe hypertriglyceridemia-induced pancreatitis during pregnancy", J Natl Med Assoc, 98(4), pp.655~ (2006)
- Ephraim RK, "Lipid profile and high maternal body mass index is associated with preeclampsia : a case-control study of the Cape Coast Metropolis", Ann Med Health Sci Res, 4(5), pp.746~750 (2014)
- Yeboah F, "Maternal adiposity and serum leptin levels at 11-13 weeks of gestation among pregnant women with gestational diabetes mellitus", Int J Med Health Sci, 5(4), pp.197~202 (2016)
- American College of Obstetricians and Gynecologists, "Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy", Obstet Gynecol, 122(5), pp.1122~ (2013)
- Jakobsdottir J, "Interpretation of genetic association studies : markers with replicated highly significant odds ratios may be poor classifiers", PLoS Genet, 5(2), pp.e1000337~ (2009)
- Ouyang Y, "Reduced plasma adiponectin and elevated leptin in pre-eclampsia", Int J Gynecol Obstet, 98(2), pp.110~114 (2007)
- Ning Y, "Relationship of maternal plasma leptin and risk of pre-eclampsia : a prospective study", J Matern Fetal Neonatal Med, 15(3), pp.186~192 (2004)
- Samolis S, "Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies–role of leptin as a marker of pre-eclampsia : a prospective case–control study", Gynecol Endocrinol, 26(5), pp.338~343 (2010)
- Hall JE, "Obesity hypertension : role of leptin and sympathetic nervous system", Am J Hypertens, 14, pp.103S~115S (2001)
- Craici IM, "Advances in the pathophysiology of pre-eclampsia and related podocyte injury", Kidney Int, 86(2), pp.275~285 (2014)
- Cesari M, "Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients", J Intern Med, 260(5), pp.474~483 (2006)
- Mazaki-Tovi S, "Maternal serum adiponectin multimers in gestational diabetes", J Perinat Med, 37(6), pp.637~650 (2009)
- D’Anna R, "Adiponectin and insulin resistance in early-and late-onset pre-eclampsia", BJOG, 113(11), pp.1264~1269 (2006)
- D'Anna R, "Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders", Obstet Gynecol, 106(2), pp.340~344 (2005)
- Khosrowbeygi A, "Maternal serum levels of adiponectin in preeclampsia", J Ayub Med Coll Abbottabad, 21(3), pp.79~82 (2009)
- Nien JK, "Adiponectin in severe preeclampsia", J Perinat Med, 35(6), pp.503~512 (2007)
- Ramsay JE, "Paradoxical elevation in adiponectin concentrations in women with preeclampsia", Hypertension, 42(5), pp.891~894 (2003)
- Fasshauer M, "Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase a in 3T3-L1 adipocytes", FEBS Lett, 507(2), pp.142~146 (2001)
- Fasshauer M, "Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes", Biochem Biophys Res Commun, 290(3), pp.1084~1089 (2002)
- Kintscher U, "Vascular protection in diabetes : a pharmacological view of angiotensin II type 1 receptor blockers", Acta Diabetol, 42, pp.s26~32 (2005)
- Danqing C, "Alterations of serum resistin in normal pregnancy and pre-eclampsia", Clin Sci, 108(1), pp.81~84 (2005)
- Chen D, "Relationship between serum resistin level and preeclampsia", Zhejiang Da Xue Bao Yi Xue Ban, 34(6), pp.503~505 (2005)
- Reilly MP, "Resistin is an inflammatory marker of atherosclerosis in humans", Circulation, 111(7), pp.932~939 (2005)
- Kendal-Wright C, "Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor(PBEF", visfatin)expression and protects them from apoptosis, 2008, pp.29(3), 255~265
- Mastorakos G, "The role of adipocytokines in insulin resistance in normal pregnancy : visfatin concentrations in early pregnancy predict insulin sensitivity", Clin Chem, 53(8), pp.1477~1483 (2007)
- Fasshauer M, "Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function", Clin Endocrinol, 66(3), pp.434~439 (2007)
- Bodnar LM, "The risk of preeclampsia rises with increasing prepregnancy body mass index", Ann Epidemiol, 15(7), pp.475~482 (2005)
- Cedergren MI, "Maternal morbid obesity and the risk of adverse pregnancy outcome", Obstet Gynecol, 103(2), pp.219~224 (2004)
- Conde-Agudelo A, "Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women", BJOG, 107(1), pp.75~83 (2000)
- Luealon P, "Risk factors of preeclampsia in Thai women", J Med Assoc Thail, 93(6), pp.661~666 (2010)
- Frühbeck G, "Pivotal role of nitric oxide in the control of blood pressure after leptin administration", Diabetes, 48(4), pp.903~908 (1999)
- Lima VJ, "Serum lipid levels in pregnancies complicated by preeclampsia", Sao Paulo Med J, 129(2), pp.73~76 (2011)
- Onat A, "Dyslipidemic hypertension : distinctive features and cardiovascular risk in a prospective population-based study", Am J Hypertens, 18(3), pp.409~416 (2005)